P363 Discontinuation of 5-aminosalicylates after starting...

P363 Discontinuation of 5-aminosalicylates after starting biologic therapy in patients with ulcerative colitis is not associated with adverse outcomes

Limketkai, B, Ungaro, R, Jess, T, Allin, K, Agrawal, M, Ullman, T, Colombel, J -F
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjx180.490
Date:
January, 2018
File:
PDF, 569 KB
english, 2018
Conversion to is in progress
Conversion to is failed